NASDAQ
Avenue Therapeutics, Inc. (ATXI) has a free cash flow growth of 48.71% as of Friday, May 29, 2026. This represents a 693.30% increase compared to its 12-month average of 6.14%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.